PRC's mRNA frontrunner is keeping pace. AIM Vaccine (06660.HK), a leading domestic vaccine company, announced today that its self-developed mRNA shingles vaccine has received clinical trial ...

PRC's mRNA frontrunner is keeping pace. AIM Vaccine (06660.HK), a leading domestic vaccine company, announced today that its self-developed mRNA shingles vaccine has received clinical trial approval ...

Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

Now, a team of scientists has developed a fresh approach: the first mRNA bird-flu vaccine for cattle. Will bird flu spark a human pandemic? Scientists say the risk is rising Early findings ...

Science and Technology Secretary Peter Kyle told the Mirror: “There are two totally transformative technologies coming together - mRNA as a tool for vaccines plus artificial intelligence.

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As clinical trials advance, Ben Hargreaves finds the technology is poised to ...

“Studies have shown that matching the content of vaccines to the circulating viruses improves protection against the disease.” Novavax’s recombinant protein-based, non-messenger RNA (mRNA), marketed ...

Healthy Americans under 65 who want an annual COVID vaccine will be out of luck under a new Food and Drug Administration policy unveiled Tuesday. Under the plan, the FDA will allow seniors and ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen ...

By Christina Jewett and Apoorva Mandavilli The Food and Drug Administration will permit use of Covid vaccines by adults over 65 and those with certain medical conditions in the fall, but may ...